An NMDA receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CGP 37849

Item No. 43660

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-amino-4-methyl-5-phosphono-3E-pentenoic acid
CAS Number
127910-31-0
Molecular Formula
C6H12NO5P
Formula Weight
209.1
Purity
≥95%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
Water: Soluble: ≥ 10 mg/ml
SMILES
O=P(O)(O)C/C(C)=C/C(N)C(O)=O
InChi Code
InChI=1S/C6H12NO5P/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5H,3,7H2,1H3,(H,8,9)(H2,10,11,12)/b4-2+
InChi Key
BDYHNCZIGYIOGJ-DUXPYHPUSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $82

    Add

    10 mg

    $156

    Add

    25 mg

    $367

    Add

    50 mg

    $692

    Add
    Product Description

    CGP 37849 is an NMDA receptor antagonist (Ki = 220 nM).1 It decreases the number of seizures induced by maximal electroshock (MES) in rats (ED50 = 21 mg/kg). CGP 37849 (0.62, 1.25, or 2.5 mg/kg) reduces immobility time in the forced swim test.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Fagg, G.E., Olpe, H.R., Pozza, M.F., et al. CGP 37849 and CGP 39551: Novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br. J. Pharmacol. 99(4), 791-797 (1990).

    2. Jin, Q., Martinez, C.A., Arcipowski, K.M., et al. USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell leukemia. Clin. Cancer Res. 25(1), 222-239 (2019).